Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure.
about
The extracellular matrix - the under-recognized element in lung disease?An ensemble method with hybrid features to identify extracellular matrix proteinsLong-term intravenous administration of carboxylated single-walled carbon nanotubes induces persistent accumulation in the lungs and pulmonary fibrosis via the nuclear factor-kappa B pathwayNon-invasive quantification of collagen turnover in renal transplant recipientsPRO-C3-levels in patients with HIV/HCV-Co-infection reflect fibrosis stage and degree of portal hypertensionAssociation of versican turnover with all-cause mortality in patients on haemodialysis.Extracellular matrix specific protein fingerprints measured in serum can separate pancreatic cancer patients from healthy controls.Target proteomic profiling of frozen pancreatic CD24+ adenocarcinoma tissues by immuno-laser capture microdissection and nano-LC-MS/MS.Serum biomarkers reflecting specific tumor tissue remodeling processes are valuable diagnostic tools for lung cancer.Stiffness-activated GEF-H1 expression exacerbates LPS-induced lung inflammationAttenuation of lipopolysaccharide-induced lung vascular stiffening by lipoxin reduces lung inflammation.Revisiting the matricellular concept.Serological assessment of neutrophil elastase activity on elastin during lung ECM remodeling.Lung extracellular matrix and fibroblast function.Novel insights into the function and dynamics of extracellular matrix in liver fibrosis.Granzyme M expressed by tumor cells promotes chemoresistance and EMT in vitro and metastasis in vivo associated with STAT3 activation.Accelerated extracellular matrix turnover during exacerbations of COPD.Matrix Metalloproteinase Mediated Type I Collagen Degradation - An Independent Risk Factor for Mortality in Women.Annexin A2 is a discriminative serological candidate in early hepatocellular carcinoma.Biglycan fragmentation in pathologies associated with extracellular matrix remodeling by matrix metalloproteinases.Value of biomarkers in osteoarthritis: current status and perspectives.Transglutaminse 2 and EGGL, the protein cross-link formed by transglutaminse 2, as therapeutic targets for disabilities of old age.Biomarkers of extracellular matrix turnover are associated with emphysema and eosinophilic-bronchitis in COPD.Republished: Value of biomarkers in osteoarthritis: current status and perspectives.Novel serological neo-epitope markers of extracellular matrix proteins for the detection of portal hypertension.Serological identification of fast progressors of structural damage with rheumatoid arthritis.The extracellular matrix in the kidney: a source of novel non-invasive biomarkers of kidney fibrosis?Redox proteomics gives insights into the role of oxidative stress in alkaptonuria.Rheumatoid arthritis: a case for personalized health care?Review article: the efficacy of biomarkers in chronic fibroproliferative diseases - early diagnosis and prognosis, with liver fibrosis as an exemplar.Biological relevance of citrullinations: diagnostic, prognostic and therapeutic options.An updated review of mechanotransduction in skin disorders: transcriptional regulators, ion channels, and microRNAs.Insights in the etiopathology of galactosyltransferase II (GalT-II) deficiency from transcriptome-wide expression profiling of skin fibroblasts of two sisters with compound heterozygosity for two novel B3GALT6 mutations.Quantitative and organisational changes in mature extracellular matrix revealed through high-content imaging of total protein fluorescently stained in situ.Cathepsin-S degraded decorin are elevated in fibrotic lung disorders - development and biological validation of a new serum biomarker.Protein degradation fragments as diagnostic and prognostic biomarkers of connective tissue diseases: understanding the extracellular matrix message and implication for current and future serological biomarkers.The minor collagens in articular cartilage.Excessive collagen turnover products are released during colorectal cancer progression and elevated in serum from metastatic colorectal cancer patients.The importance of serum biglycan levels as a fibrosis marker in patients with chronic hepatitis B.Circulating Elastin Fragments Are Not Affected by Hepatic, Renal and Hemodynamic Changes, But Reflect Survival in Cirrhosis with TIPS.
P2860
Q28075842-63A353B3-0773-4677-90AB-33A8FE37A365Q28543516-D0DAD7D1-5978-4D7B-8CF3-486F31404721Q29247884-D8D5BC10-00D6-4E54-A54B-E0D4210F5D70Q33590296-6546497C-F6F6-48C9-B322-93469D5D8F40Q34268818-0DF09468-1938-4E6A-A291-B29A3CAC95B9Q34420828-FFE52E08-B348-4269-A6F0-D0E275ECA2F8Q34463741-817256F4-9F1B-4D35-824D-9EEA6794098BQ34725880-B61F9EF5-8F05-4F49-8AF0-4DA310464239Q34998455-AA53D690-492B-4BF0-A90A-F57CDDE4B633Q35150381-C8F35C19-AC69-40F0-B8C1-685C7CBEC88FQ35207657-B20352D4-25B4-4304-BC95-73EFBD9EBFF9Q35233858-4508FCA3-CB51-44A3-A92D-2755FD5563C1Q35590577-1ADB1754-9B90-478C-B204-75E334C8C991Q35604453-67DB5288-776C-4BE3-B1BF-17EA0B66A1C0Q35622533-14B2CED5-E17B-4C67-BCAB-5F77188B9615Q35742411-02702A0F-59F3-4688-B69A-183931F90F18Q35816871-1D76E108-4A6E-48B3-9512-CA976CC5BD4EQ35947519-A3AC5F90-CAAD-426F-89AC-0F080009A5A0Q36636344-9CD97485-96A1-48FF-BAEA-7EF4C7AF6A87Q36835374-F5687638-1F9D-43C2-93CB-752548A6E16AQ37267571-C70760A5-92A7-4938-90DF-4F6B102D07B0Q37406648-1A02F53D-52AD-4380-B974-C81B4428BEE0Q37595806-B933AF83-A4DD-4DAA-B501-74C086501E4AQ37602869-33D97763-FFA8-4FC9-9494-2DD09C4CD25AQ37604322-5B8B6A79-5CBC-4C16-AEEF-4355DA1562B3Q37689708-C8197C23-9775-4A00-93E4-447AE6390E0DQ37702664-1AF51DD3-50C7-49BB-914B-FA646EC792F8Q38160929-AE39D1EC-32B6-48A1-AC36-900F1CDC5605Q38182471-B7ABB9AC-BB07-4EF5-B8BC-4E7904C09006Q38218544-5C752704-4995-44AE-B3CF-FFB826A51123Q38292450-4FA5137B-A638-455A-9031-1B17EF359770Q38355578-15CF7217-082F-45C0-8051-B52C40C7AE7CQ38470441-36660DA3-1BAE-4198-9D95-49E57253022DQ38601581-80575CC3-405A-4445-9117-26FC9A8B4356Q38631861-C39DD652-E86C-4BC1-819E-03577E80D8CBQ38675211-8A1A2D32-21DA-476F-A12A-02B85F4517A0Q39141588-E25F55FA-F9F8-4BB4-8B04-5D903B2A011CQ39553253-F49DAD2A-EE7C-464C-906A-AFCC77EB2B42Q40437910-07E77ADE-4E5B-4A8E-89CD-FBC0FE57EDD7Q40772599-BCF7333A-AFFE-49EB-93DA-F9BBC8DFEBA2
P2860
Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Extracellular matrix remodelin ...... key player in tissue failure.
@ast
Extracellular matrix remodelin ...... key player in tissue failure.
@en
type
label
Extracellular matrix remodelin ...... key player in tissue failure.
@ast
Extracellular matrix remodelin ...... key player in tissue failure.
@en
prefLabel
Extracellular matrix remodelin ...... key player in tissue failure.
@ast
Extracellular matrix remodelin ...... key player in tissue failure.
@en
P2093
P2860
P50
P356
P1476
Extracellular matrix remodelin ...... key player in tissue failure.
@en
P2093
Anne-Christine Bay-Jensen
Claus Christiansen
Diana J Leeming
Joanne I Adamkewicz
Kim Henriksen
Morten A Karsdal
Victoria Smith
P2860
P356
10.1089/ADT.2012.474
P577
2012-10-09T00:00:00Z